Tumor suppressor Pdcd4 attenuates Sin1 translation to inhibit invasion in colon carcinoma
Open accessAbstract
Programmed cell death 4 (Pdcd4), a tumor invasion suppressor, is frequently downregulated in colorectal cancer and other cancers. In this study, we find that loss of Pdcd4 increases the activity of mammalian target of rapamycin complex 2 (mTORC2) and thereby upregulates Snail expression. Examining the components of mTORC2 showed that Pdcd4 knockdown increased the protein but not mRNA level of stress-activated-protein kinase interacting protein 1 (Sin1), which resulted from enhanced Sin1 translation. To understand how Pdcd4 regulates Sin1 translation, the SIN1 5' untranslated region (5'UTR) was fused with luciferase reporter and named as 5'Sin1-Luc. Pdcd4 knockdown/knockout significantly increased the translation of 5'Sin1-Luc but not the control luciferase without the SIN1 5'UTR, suggesting that Sin1 5'UTR is necessary for Pdcd4 to inhibit Sin1 translation. Ectopic expression of wild-type Pdcd4 and Pdcd4(157-469), a deletion mutant that binds to translation initiation factor 4A (eIF4A), sufficiently inhibited Sin1 translation, and thus suppressed mTORC2 kinase activity and invasion in colon tumor cells. By contrast, Pdcd4(157-469)(D253A,D418A), a mutant that does not bind to eIF4A, failed to inhibit Sin1 translation, and consequently failed to repress mTORC2 activity and invasion. In addition, directly inhibiting eIF4A with silvestrol significantly suppressed Sin1 translation and attenuated invasion. These results indicate that Pdcd4-inhibited Sin1 translation is through suppressing eIF4A, and functionally important for suppression of mTORC2 activity and invasion. Moreover, in colorectal cancer tissues, the Sin1 protein but not mRNA was significantly upregulated while Pdcd4 protein was downregulated, suggesting that loss of Pdcd4 might correlate with Sin1 protein level but not mRNA level in colorectal cancer patients. Taken together, our work reveals a novel mechanism by which Pdcd4 inhibits Sin1 translation to attenuatemTORC2 activity and thereby suppresses invasion.
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The mRNAs of TP53 and SIN1 are physiological translational targets of PDCD4.
“It was reported that the mRNAs of the tumor suppressor TP53 and stress-activated-protein kinase interacting protein-1 (SIN1) are such physiological translational targets of PDCD4 [25,26].”
From Control Mechanisms of the Tumor Suppressor PDCD4: Expression and Functions (2019) · cites this paper as [26]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Cites
The phosphatidylinositol 3-Kinase–AKT pathway in human cancer
Vivanco, I., & Sawyers, C. L. (2002) · Nature reviews. Cancer · doi:10.1038/nrc839 · Cited by 6,041 · see citing works
TOR signaling in growth and metabolism
Wullschleger, S., Loewith, R., & Hall, M. N. (2006) · Cell · doi:10.1016/j.cell.2006.01.016 · Cited by 5,787 · see citing works
Defining the role of mTOR in cancer
Guertin, D. A., & Sabatini, D. M. (2007) · Cancer Cell · doi:10.1016/j.ccr.2007.05.008 · Cited by 2,833 · see citing works
Zhou, B. P., Deng, J., Xia, W., Xu, J., Li, Y. M., Gunduz, M., & Hung, M.-C. (2004) · Nature Cell Biology · doi:10.1038/ncb1173 · Cited by 1,581 · see citing works
S6K1- and ßTRCP-Mediated Degradation of PDCD4 Promotes Protein Translation and Cell Growth
Dorrello, N. V., Peschiaroli, A., Guardavaccaro, D., Colburn, N. H., Sherman, N. E., & Pagano, M. (2006) · Science · doi:10.1126/science.1130276 · Cited by 731 · see citing works
Self-citationPI3K/Akt: getting it right matters
Franke, T. F. (2008) · Oncogene · doi:10.1038/onc.2008.313 · Cited by 696 · see citing works
RNA G-quadruplexes cause eIF4A-dependent oncogene translation in cancer
Wolfe, A. L., Singh, K., Zhong, Y., Drewe, P., Rajasekhar, V. K., Sanghvi, V. R., Mavrakis, K. J., Jiang, M., Roderick, J. E., Van der Meulen, J., et al. (2014) · Nature · doi:10.1038/nature13485 · Cited by 635 · see citing works
Gulhati, P., Bowen, K. A., Liu, J., Stevens, P. D., Rychahou, P. G., Chen, M., Lee, E. Y., Weiss, H. L., O’Connor, K. L., Gao, T., et al. (2011) · Cancer Research · doi:10.1158/0008-5472.can-10-4058 · Cited by 544 · see citing works
Self-citationYang, H.-S., Jansen, A. P., Komar, A. A., Zheng, X., Merrick, W. C., Costes, S., Lockett, S. J., Sonenberg, N., & Colburn, N. H. (2003) · Molecular and Cellular Biology · doi:10.1128/mcb.23.1.26-37.2003 · Cited by 494 · see citing works
Self-citationSvitkin, Y. V., Pause, A., Haghighat, A., Pyronnet, S., Witherell, G. W., Belsham, G. J., & Sonenberg, N. (2001) · RNA · doi:10.1017/s135583820100108x · Cited by 477 · see citing works
Activation of NF-κB by Akt upregulates Snail expression and induces epithelium mesenchyme transition
Julien-Grille, S., Puig, I., Caretti, E., Bonaventure, J., Nelles, L., Roy, F. M. V., Dargemont, C., de Herreros, A. G., Bellacosa, A., & Larue, L. (2007) · Oncogene · doi:10.1038/sj.onc.1210546 · Cited by 476 · see citing works
PtdIns(3,4,5) P 3-Dependent Activation of the mTORC2 Kinase Complex
Liu, P., Gan, W., Chin, Y. R., Ogura, K., Guo, J., Zhang, J., Wang, B., Blenis, J., Cantley, L. C., Toker, A., et al. (2015) · Cancer Discovery · doi:10.1158/2159-8290.cd-15-0460 · Cited by 385 · see citing works
Antitumor Activity and Mechanism of Action of the Cyclopenta[b]benzofuran, Silvestrol
Cencic, R., Carrier, M., Galicia-Vázquez, G., Bordeleau, M.-E., Sukarieh, R., Bourdeau, A., Brem, B., Teodoro, J. G., Greger, H., Tremblay, M. L., et al. (2009) · PLoS ONE · doi:10.1371/journal.pone.0005223 · Cited by 302 · see citing works
A Positive Feedback Loop between Akt and mTORC2 via SIN1 Phosphorylation
Yang, G., Murashige, D., Humphrey, S. J., & James, D. E. (2015) · Cell Reports · doi:10.1016/j.celrep.2015.07.016 · Cited by 297 · see citing works
eIF4A: The godfather of the DEAD box helicases
Rogers, G. W., Komar, A. A., & Merrick, W. C. (2002) · Progress in nucleic acid research and molecular biology · doi:10.1016/s0079-6603(02)72073-4 · Cited by 274 · see citing works
Liu, P., Gan, W., Inuzuka, H., Lazorchak, A. S., Gao, D., Arojo, O., Liu, D., Wan, L., Zhai, B., Yu, Y., et al. (2013) · Nature Cell Biology · doi:10.1038/ncb2860 · Cited by 256 · see citing works
Masri, J., Bernath, A., Martin, J., Jo, O. D., Vartanian, R., Funk, A., & Gera, J. (2007) · Cancer Research · doi:10.1158/0008-5472.can-07-2223 · Cited by 253 · see citing works
Epidermal Expression of the Translation Inhibitor Programmed Cell Death 4 Suppresses Tumorigenesis
Jansen, A. P., Camalier, C. E., & Colburn, N. H. (2005) · Cancer Research · doi:10.1158/0008-5472.can-04-2119 · Cited by 212 · see citing works
Self-citationYang, H.-S., Matthews, C. P., Clair, T., Wang, Q., Baker, A. R., Li, C.-C. H., Tan, T.-H., & Colburn, N. H. (2006) · Molecular and Cellular Biology · doi:10.1128/mcb.26.4.1297-1306.2006 · Cited by 202 · see citing works
Self-citationYang, H.-S., Cho, M.-H., Zakowicz, H., Hegamyer, G., Sonenberg, N., & Colburn, N. H. (2004) · Molecular and Cellular Biology · doi:10.1128/mcb.24.9.3894-3906.2004 · Cited by 199 · see citing works
Self-citationStrezoska, Ž., Pestov, D. G., & Lau, L. F. (2000) · Molecular and Cellular Biology · doi:10.1128/mcb.20.15.5516-5528.2000 · Cited by 185 · see citing works
Gulhati, P., Cai, Q., Li, J., Liu, J., Rychahou, P. G., Qiu, S., Lee, E. Y., Silva, S. R., Bowen, K. A., Gao, T., et al. (2009) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-09-1249 · Cited by 177 · see citing works
Self-citationTranslational Regulation of Autoimmune Inflammation and Lymphoma Genesis by Programmed Cell Death 4
Hilliard, A., Hilliard, B., Zheng, S.-J., Sun, H., Miwa, T., Song, W., Göke, R., & Chen, Y. H. (2006) · The Journal of Immunology · doi:10.4049/jimmunol.177.11.8095 · Cited by 167 · see citing works
Leupold, J. H., Yang, H.-S., Colburn, N. H., Asangani, I., Post, S., & Allgayer, H. (2007) · Oncogene · doi:10.1038/sj.onc.1210234 · Cited by 163 · see citing works
Self-citationGaubitz, C., Prouteau, M., Kuśmider, B., & Loewith, R. (2016) · Trends in Biochemical Sciences · doi:10.1016/j.tibs.2016.04.001 · Cited by 160 · see citing works
Wang, Q., Sun, Z., & Yang, H. (2007) · Oncogene · doi:10.1038/sj.onc.1210793 · Cited by 147 · see citing works
Self-citationStructural basis for translational inhibition by the tumour suppressor Pdcd4
Loh, P. G., Yang, H., Walsh, M. A., Wang, Q., Wang, X., Cheng, Z., Liu, D. X., & Song, H. (2009) · The EMBO Journal · doi:10.1038/emboj.2008.278 · Cited by 125 · see citing works
Self-citationCrystal structure of the eIF4A–PDCD4 complex
Chang, J. H., Cho, Y. H., Sohn, S. Y., Choi, J. M., Kim, A., Kim, Y. C., Jang, S. K., & Cho, Y. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0808275106 · Cited by 120 · see citing works
Wiegering, A., Uthe, F. W., Jamieson, T. J., Ruoss, Y., Hüttenrauch, M., Küspert, M., Pfann, C., Nixon, C., Herold, S., Walz, S., et al. (2015) · Cancer Discovery · doi:10.1158/2159-8290.cd-14-1040 · Cited by 113 · see citing works
Liwak, U., Thakor, N., Jordan, L. E., Roy, R., Lewis, S. M., Pardo, O. E., Seckl, M., & Holcik, M. (2012) · Molecular and Cellular Biology · doi:10.1128/mcb.06317-11 · Cited by 106 · see citing works
Wang, Q., Sun, Z. X., Allgayer, H., & Yang, H. S. (2010) · Oncogene · doi:10.1038/onc.2009.302 · Cited by 89 · see citing works
Self-citationGlidden, E. J., Gray, L. G., Vemuru, S., Li, D., Harris, T. E., & Mayo, M. W. (2011) · Journal of Biological Chemistry · doi:10.1074/jbc.m111.304337 · Cited by 88 · see citing works
Targeting mTORC2 inhibits colon cancer cell proliferation in vitro and tumor formation in vivo
Roulin, D., Cerantola, Y., Dormond-Meuwly, A., Demartines, N., & Dormond, O. (2010) · Molecular Cancer · doi:10.1186/1476-4598-9-57 · Cited by 88 · see citing works
Nieves-Alicea, R., Colburn, N. H., Simeone, A., & Tari, A. M. (2008) · Breast Cancer Research and Treatment · doi:10.1007/s10549-008-9993-5 · Cited by 86 · see citing works
Self-citationTherapeutic Potential of the Translation Inhibitor Silvestrol in Hepatocellular Cancer
Kogure, T., Kinghorn, A. D., Yan, I. K., Bolon, B. N., Lucas, D. M., Grever, M. R., & Patel, T. C. (2013) · PLoS ONE · doi:10.1371/journal.pone.0076136 · Cited by 68 · see citing works
Pdcd4 repression of lysyl oxidase inhibits hypoxia-induced breast cancer cell invasion
Santhanam, A. N., Baker, A. R., Hegamyer, G., Kirschmann, D. A., & Colburn, N. H. (2010) · Oncogene · doi:10.1038/onc.2010.158 · Cited by 67 · see citing works
Self-citationChapter 11 Monitoring Mammalian Target of Rapamycin (mTOR) Activity
Ikenoue, T., Hong, S., & Inoki, K. (2009) · Methods in enzymology on CD-ROM/Methods in enzymology · doi:10.1016/s0076-6879(08)03611-2 · Cited by 62 · see citing works
Tumour Suppressive Function and Modulation of Programmed Cell Death 4 (PDCD4) in Ovarian Cancer
Wei, N., Liu, S. S., Chan, K. K. L., & Ngan, H. (2012) · PLoS ONE · doi:10.1371/journal.pone.0030311 · Cited by 58 · see citing works
PDCD4 inhibits the malignant phenotype of ovarian cancer cells
Wei, Z., Zhang, X., Wang, X., Gao, F., Zhou, C., Zhu, F., Wang, Q., Gao, Q., Ma, C., Sun, W., et al. (2009) · Cancer Science · doi:10.1111/j.1349-7006.2009.01210.x · Cited by 54 · see citing works
Self-citationThe mTOR (Mammalian Target of Rapamycin) Kinase Maintains Integrity of mTOR Complex 2
Chen, C.-H., & Sarbassov, D. D. (2011) · Journal of Biological Chemistry · doi:10.1074/jbc.m111.282590 · Cited by 49 · see citing works
Xu, J., Li, X., Yang, H., Chang, R., Kong, C., & Yang, L. (2013) · Cancer · doi:10.1002/cncr.28023 · Cited by 43 · see citing works
Self-citationWang, Q., Zhang, Y., & Yang, H. (2012) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/j.bbamcr.2012.07.004 · Cited by 41 · see citing works
Self-citationAKT Activation by Pdcd4 Knockdown Up-Regulates Cyclin D1 Expression and Promotes Cell Proliferation
Guo, X., Li, W., Wang, Q., & Yang, H.-S. (2011) · Genes & Cancer · doi:10.1177/1947601911431082 · Cited by 40 · see citing works
Self-citationFehler, O., Singh, P., Haas, A., Ulrich, D., Müller, J. P., Ohnheiser, J., & Klempnauer, K.-H. (2014) · Nucleic Acids Research · doi:10.1093/nar/gku800 · Cited by 35 · see citing works
Zhang, Y., Wang, Q., Chen, L., & Yang, H. (2015) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-14-0648 · Cited by 28 · see citing works
Self-citationWang, Q., Zhu, J., Zhang, Y., Sun, Z., Guo, X., Wang, X., Lee, E. Y., Bakthavatchalu, V., Yang, Q., & Yang, H. (2013) · European Journal of Cancer · doi:10.1016/j.ejca.2012.12.014 · Cited by 27 · see citing works
Self-citationLankat–Buttgereit, B., Müller, S., Schmidt, H., Parhofer, K. G., Gress, T. M., & Göke, R. (2008) · Biology of the Cell · doi:10.1042/bc20080052 · Cited by 25 · see citing works
Translation and Its Regulation in Cancer Biology and Medicine
Parsyan, A. E. (2014) · Springer eBooks · doi:10.1007/978-94-017-9078-9 · Cited by 20 · see citing works
Moraitis, D., Karanikou, M., Liakou, C., DIMAS, K. S., Tzimas, G. N., Tseleni‐Balafouta, S., Patsouris, E., Rassidakis, G. Z., & Kouvaraki, M. A. (2014) · Surgery · doi:10.1016/j.surg.2014.08.095 · Cited by 18 · see citing works
Yang, H., Wang, Q., Bajer, M. M., & Schmid, T. (2014) · Springer eBooks · doi:10.1007/978-94-017-9078-9_6 · Cited by 3 · see citing works
Self-citation
Flagged first, then by citations
Research works printed but not linked: 1
- [49]Ikenoue T Hong S Inoki K Monitoring mammalian target of rapamycin (mTOR) activity Methods Enzymol 2009 452 165 180 19200882
Cited by
Sorted by citations
Regulation and metabolic functions of mTORC1 and mTORC2.
Szwed, A., Kim, E., & Jacinto, E. (2021) · Physiological Reviews · doi:10.1152/physrev.00026.2020 · Cited by 723 · see citing works
Large-Scale Topological Changes Restrain Malignant Progression in Colorectal Cancer
Johnstone, S. E., Reyes, A., Qi, Y., Adriaens, C., Hegazi, E., Pelka, K., Chen, J. H., Zou, L.-L., Drier, Y., Hecht, V. C., et al. (2020) · Cell · doi:10.1016/j.cell.2020.07.030 · Cited by 189 · see citing works
Control Mechanisms of the Tumor Suppressor PDCD4: Expression and Functions
Matsuhashi, S., Manirujjaman, M., Hamajima, H., & Ozaki, I. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20092304 · Cited by 143 · see citing works
Protein translation: biological processes and therapeutic strategies for human diseases
Jia, X., He, X., Huang, C., Li, J., Dong, Z., & Liu, K. (2024) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-024-01749-9 · Cited by 143 · see citing works
The role of Pdcd4 in tumour suppression and protein translation
Wang, Q., & Yang, H. (2018) · Biology of the Cell · doi:10.1111/boc.201800014 · Cited by 113 · see citing works
Self-citationThe mTORC2 signaling network: targets and cross-talks
Ragupathi, A., Kim, C., & Jacinto, E. (2024) · Biochemical Journal · doi:10.1042/bcj20220325 · Cited by 113 · see citing works
Yin, Y., Zhao, B., Li, D., & Yin, G. (2018) · Cell & Bioscience · doi:10.1186/s13578-018-0240-4 · Cited by 59 · see citing works
RetractedZheng, Y., Zhao, P., Lian, Y., Li, S., Chen, Y., & Li, L. (2019) · Neurochemistry International · doi:10.1016/j.neuint.2019.104650 · Cited by 57 · see citing works
Li, Y., Jia, Y., Wang, D., Zhuang, X., Li, Y., Guo, C., Chu, H., Zhu, F., Wang, J., Wang, X., et al. (2021) · Molecular Psychiatry · doi:10.1038/s41380-020-0692-x · Cited by 56 · see citing works
Self-citationProgrammed cell death factor 4 (PDCD4), a novel therapy target for metabolic diseases besides cancer
Lu, K., Chen, Q., Li, M., He, L., Riaz, F., Zhang, T., & Li, D. (2020) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2020.06.016 · Cited by 53 · see citing works
Ye, Y., Yang, S., Han, Y., Sun, J., Xv, L., Wu, L., Wang, Y., & Ming, L. (2018) · Aging · doi:10.18632/aging.101488 · Cited by 49 · see citing works
Self-citationIGF-1R inhibition induces MEK phosphorylation to promote survival in colon carcinomas
Wang, Q., Zhang, Y., Zhu, J., Zheng, H., Chen, S., Chen, L., & Yang, H. (2020) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-020-0204-0 · Cited by 43 · see citing works
Self-citationThe mechanisms and clinical significance of PDCD4 in colorectal cancer
Long, J., Yin, Y., Guo, H., Li, S., Sun, Y., Zeng, C., & Zhu, W. (2018) · Gene · doi:10.1016/j.gene.2018.09.034 · Cited by 40 · see citing works
Hidalgo-Estévez, A. M., Stamatakis, K., Jiménez-Martínez, M., López‐Pérez, R., & Fresno, M. (2020) · Frontiers in Pharmacology · doi:10.3389/fphar.2020.00533 · Cited by 42 · see citing works
Dissecting the Roles of PDCD4 in Breast Cancer
Cai, Q., Yang, H., Li, Y., & Zhu, J. (2022) · Frontiers in Oncology · doi:10.3389/fonc.2022.855807 · Cited by 37 · see citing works
Self-citationThe Regulatory Role of Non-coding RNAs on Programmed Cell Death Four in Inflammation and Cancer
Zhao, M., Zhu, N., Hao, F., Song, Y., Wang, Z., Ni, Y., & Ding, L. (2019) · Frontiers in Oncology · doi:10.3389/fonc.2019.00919 · Cited by 36 · see citing works
Hua, R., Zhang, X., Li, W., Lian, W., Liu, Q., Gao, D., Wang, Y., & Lei, M. (2020) · Journal of Cell Science · doi:10.1242/jcs.248898 · Cited by 35 · see citing works
Self-citationStress granules in colorectal cancer: Current knowledge and potential therapeutic applications
Legrand, N., Dixon, D. A., & Sobolewski, C. (2020) · World Journal of Gastroenterology · doi:10.3748/wjg.v26.i35.5223 · Cited by 29 · see citing works
Paolo, A. D., Eastman, G., Mesquita-Ribeiro, R., Farías, J., Macklin, A. M., Kislinger, T., Colburn, N. H., Munroe, D. J., Sosa, J. R. S., Dajas‐Bailador, F., et al. (2020) · RNA · doi:10.1261/rna.075424.120 · Cited by 28 · see citing works
Self-citationTargeting translation regulators improves cancer therapy.
Jiang, S.-L., Mo, J.-L., Peng, J., Lei, L., Yin, J.-Y., Zhou, H.-H., Hong, W., & Liu, Z.-Q. (2020) · Genomics · doi:10.1016/j.ygeno.2020.11.011 · Cited by 25 · see citing works
Sin1-mediated mTOR signaling in cell growth, metabolism and immune response
Ruan, C.-H., Ouyang, X.-X., Liu, H.-Z., Li, S., Jin, J.-S., Tang, W.-T., Xia, Y.-J., & Su, B. (2019) · National Science Review · doi:10.1093/nsr/nwz171 · Cited by 20 · see citing works
Curcumin exerts its antitumor effects in a context dependent fashion
Kreutz, D., Sinthuvanich, C., Bileck, A., Janker, L., Muqaku, B., Slany, A., & Gerner, C. (2018) · Journal of Proteomics · doi:10.1016/j.jprot.2018.05.007 · Cited by 24 · see citing works
Programmed cell death 4 modulates lysosomal function by inhibiting TFEB translation
Chen, X., Guan, Y., Zhang, Y., Jia, Y., Li, W., Guo, C., Li, Y., Wang, X., Shi, Y., Wang, Q., et al. (2021) · Cell Death & Differentiation · doi:10.1038/s41418-020-00646-2 · Cited by 24 · see citing works
Self-citationWu, Y., Zhu, X., Shen, R., Huang, J., Xu, X. N., & He, S. (2019) · Pathology - Research and Practice · doi:10.1016/j.prp.2019.152603 · Cited by 23 · see citing works
Nitidine Chloride Inhibits SIN1 Expression in Osteosarcoma Cells
Xu, H., Cao, T., Zhang, X., Shi, Y., Zhang, Q., Chai, S., Li, Y., Jin, G., Ma, J., Wang, Z. P., et al. (2019) · Molecular Therapy — Oncolytics · doi:10.1016/j.omto.2019.01.005 · Cited by 21 · see citing works
EIF3H interacts with PDCD4 enhancing lung adenocarcinoma cell metastasis.
Hu, Y., Xiao, W. L., Lv, Y., Xie, X., Liu, Y., He, J., Tao, X., Ma, Y., Su, Y., Wu, L., et al. (2020) · PubMed Central · Cited by 21 · see citing works
Zeng, J., Xu, H., Huang, C., Sun, Y. E., Xiao, H., Gan, Y., Zhou, H., Zhang, Y., Yao, W., Xiao, W., et al. (2021) · Molecular Therapy — Nucleic Acids · doi:10.1016/j.omtn.2021.02.019 · Cited by 20 · see citing works
Favero, G. D., Woelflingseder, L., Janker, L., Neuditschko, B., Seriani, S., Gallina, P., Sbaizero, O., Gerner, C., & Marko, D. (2018) · Scientific Reports · doi:10.1038/s41598-018-29728-5 · Cited by 20 · see citing works
Cai, Y., Zhao, X., Chen, D., Zhang, F., Chen, Q., Shao, C.-C., Ouyang, Y.-X., Feng, J. L., Cui, L., Chen, M., et al. (2021) · Molecular Therapy — Nucleic Acids · doi:10.1016/j.omtn.2021.09.013 · Cited by 19 · see citing works
Degradation of the Tumor Suppressor PDCD4 Is Impaired by the Suppression of p62/SQSTM1 and Autophagy
Manirujjaman, M., Ozaki, I., Murata, Y., Guo, J. H., Xia, J., Nishioka, K., Perveen, R., Takahashi, H., Anzai, K., & Matsuhashi, S. (2020) · Cells · doi:10.3390/cells9010218 · Cited by 18 · see citing works
Wen, C., Feng, X., Yuan, H., Gong, Y. S., & Wang, G. (2021) · BMC Cancer · doi:10.1186/s12885-021-07997-0 · Cited by 18 · see citing works
Zhang, Q., Peng, J., Zhang, Y., Liu, J., He, D., Zhao, Y., Wang, X., Li, C., Kong, Y., Wang, R., et al. (2025) · Science Signaling · doi:10.1126/scisignal.adi5174 · Cited by 17 · see citing works
Self-citationQuerido, J. B., Sokabe, M., Díaz‐López, I., Gordiyenko, Y., Zuber, P. K., Du, Y., Albacete-Albacete, L., Ramakrishnan, V., & Fraser, C. S. (2024) · Nature Communications · doi:10.1038/s41467-024-50672-8 · Cited by 16 · see citing works
Walker, N., Mazzoni, S. M., Vittal, R., Fingar, D. C., & Lama, V. N. (2018) · Journal of Biological Chemistry · doi:10.1074/jbc.ra118.003926 · Cited by 16 · see citing works
Pdcd4 promotes lipid deposition by attenuating PPARα-mediated fatty acid oxidation in hepatocytes
Du, X., Osoro, E. K., Chen, Q., Yan, X., Gao, D., Wu, L., Ren, J., Feng, L., Wu, N., Lu, K., et al. (2022) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2022.111562 · Cited by 16 · see citing works
Unmasking the tumourigenic role of SIN1/MAPKAP1 in the mTOR complex 2
Ezine, E., Lebbé, C., & Dumaz, N. (2023) · Clinical and Translational Medicine · doi:10.1002/ctm2.1464 · Cited by 14 · see citing works
Haas, A., Nilges, B. S., Leidel, S. A., & Klempnauer, K. (2020) · Scientific Reports · doi:10.1038/s41598-020-59678-w · Cited by 14 · see citing works
Duan, X., Li, W., Hu, P., Jiang, B., Yang, J., Zhou, L., Mao, X., & Tian, B. (2020) · Bioscience Reports · doi:10.1042/bsr20201761 · Cited by 13 · see citing works
Advances in the study of the relationship between Porphyromonas gingivalis and various diseases
Zou, Q., Xie, H., Yang, W., Xu, J., Ying, S., Liao, X., Xie, J. H., Wu, X., & Meng, F. (2025) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2025.1480233 · Cited by 12 · see citing works
Huang, Y., Feng, G., Cai, J., Peng, Q., Yang, Z., Yan, C., Yang, L., & Wang, Z. (2020) · Life Sciences · doi:10.1016/j.lfs.2020.117449 · Cited by 12 · see citing works
Peron, G., Mastinu, A., Peña‐Corona, S. I., Hernández‐Parra, H., Leyva‐Gómez, G., Călina, D. C., & Sharifi‐Rad, J. (2024) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2024.117047 · Cited by 11 · see citing works
Neuronal activity regulates the nuclear proteome to promote activity-dependent transcription
Herbst, W. A., Deng, W., Wohlschlegel, J. A., Achiro, J. M., & Martin, K. C. (2021) · The Journal of Cell Biology · doi:10.1083/jcb.202103087 · Cited by 11 · see citing works
The Impact of Pdcd4, a Translation Inhibitor, on Drug Resistance
Wang, Q., & Yang, H. (2024) · Pharmaceuticals · doi:10.3390/ph17101396 · Cited by 10 · see citing works
Self-citationThe RNA-binding protein AUF1 facilitates Akt phosphorylation at the membrane
Li, M.-L., Ragupathi, A., Patel, N., Hernandez, T., Magsino, J., Werlen, G., Brewer, G., & Jacinto, E. (2022) · Journal of Biological Chemistry · doi:10.1016/j.jbc.2022.102437 · Cited by 10 · see citing works
Feng, G., Cai, J., Huang, Y., Zhu, X., Gong, B., Yang, Z., Yan, C., Hu, Z., Yang, L., & Wang, Z. (2020) · Molecular Cancer Research · doi:10.1158/1541-7786.mcr-20-0173 · Cited by 9 · see citing works
Cao, B., Chen, X., Li, Y., Zhou, T., Chen, N., Guo, Y., Zhao, M., Guo, C., Shi, Y., Wang, Q., et al. (2024) · npj Parkinson's Disease · doi:10.1038/s41531-024-00760-9 · Cited by 8 · see citing works
Self-citationDeng, C., Li, C., Dong, X. D., Yu, Y., Guo, W., Guan, Y., Sun, X., & Cao, L. (2023) · Communications Biology · doi:10.1038/s42003-023-05656-7 · Cited by 8 · see citing works
Role of mammalian target of rapamycin complex 2 in primary and secondary liver cancer
Joechle, K., Guenzle, J., Hellerbrand, C., Strnad, P., Cramer, T., Neumann, U. P., & Lang, S. A. (2021) · World Journal of Gastrointestinal Oncology · doi:10.4251/wjgo.v13.i11.1632 · Cited by 8 · see citing works
Tumor Suppressor p53 Down-Regulates Programmed Cell Death Protein 4 (PDCD4) Expression
Yang, W. H., George, A. P., Wang, C., Yang, R. H., Duncan, A. M., Patel, D., Neil, Z. D., & Yang, W. (2023) · Current Oncology · doi:10.3390/curroncol30020124 · Cited by 6 · see citing works
Self-citationBartkowiak, K., Mohammadi, P. M., Nissen, P., Werner, S., Agorku, D., Andreas, A., Geffken, M., Peine, S., Verpoort, K., Deutsch, T. M., et al. (2025) · Scientific Reports · doi:10.1038/s41598-025-87122-4 · Cited by 5 · see citing works
Wang, Q., He, W., Han, S., Li, M., Wang, Y., Zaytseva, Y. Y., Chen, L., Zhu, J., & Yang, H. (2025) · Cancer Medicine · doi:10.1002/cam4.71145 · Cited by 2 · see citing works
Self-citationPerveen, R., Ozaki, I., Manirujjaman, M., Mine, K., Murata, Y., Tanaka, K., Xia, J., Takahashi, H., Anzai, K., & Matsuhashi, S. (2022) · Human Cell · doi:10.1007/s13577-022-00844-9 · Cited by 3 · see citing works
Low PDCD4 Expression Is Associated With Poor Prognosis of Colorectal Carcinoma
Kim, J. Y., Lee, H., Kim, E., Lee, W. M., Hong, Y. O., & Hong, S. A. (2021) · Applied immunohistochemistry & molecular morphology · doi:10.1097/pai.0000000000000948 · Cited by 3 · see citing works
L-3,4-Dihydroxy-6-[18F]fluorophenylalanine
Leung, K. (2011) · Europe PMC (PubMed Central) · Cited by 2 · see citing works
Ahmed, A. A., Monir, M., Sabry, D., & Mostafa, A. (2023) · Beni-Suef University Journal of Basic and Applied Sciences · doi:10.1186/s43088-023-00351-2 · Cited by 1 · see citing works
Mutant NPM1 modulates PDCD4 ubiquitination degradation and facilitates leukemogenesis
Liang, C., Ke, J., Zhang, Z., Guo, H., Shang, H., Liu, D., Li, S., & Wu, F. (2025) · iScience · doi:10.1016/j.isci.2025.113776 · Cited by 1 · see citing works
Qi, J., Zhang, Z., Yin, J., Yuan, X., Wang, X., Liu, Z., Liu, Y., & Wang, J. (2026) · Journal of Stroke and Cerebrovascular Diseases · doi:10.1016/j.jstrokecerebrovasdis.2026.108554 · Cited by 1 · see citing works
Role of PDCD4 in inflammation and tumors: a double-edged sword
Jia, Y., Chen, X., & Zhang, L. (2018) · Scientia Sinica Vitae · doi:10.1360/n052018-00164
NOVEL COMPUTATIONAL METHODS FOR CANCER GENOMICS DATA ANALYSIS
Liu, J. (2021) · UKnowledge (University of Kentucky) · doi:10.13023/etd.2021.215
Self-citationCole, M., & Schaafsma, E. (2020) · Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature · doi:10.3410/f.738541400.793579087
Human tumor suppressor protein Pdcd4 binds at the mRNA entry channel in 40S small ribosomal subunitPreprint
Querido, J. B., Sokabe, M., Díaz‐López, I., Gordiyenko, Y., Zuber, P. K., Du, Y., Albacete-Albacete, L., Ramakrishnan, V., & Fraser, C. S. (2024) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2024.05.01.592117
Gao, X. Y., Liang, Z., Yuan, Y., & Liu, W. (2024) · Science of Advanced Materials · doi:10.1166/sam.2024.4636
Phosphorylation of USP33 by CDK1 stabilizes the mTORC2 component SIN1
Wen, Y., Zhang, C., Liang, M., Yang, X. J., Zeng, H., Wan, R., Ma, X., Huang, L., Li, M., Zhang, Q., et al. (2025) · Cell Death and Disease · doi:10.1038/s41419-025-07869-6
PDCD4: A Double-Edged Sword in Neurological Diseases
Li, C., Zheng, K., Qiu, M. S., & Yang, J. (2026) · Molecular Neurobiology · doi:10.1007/s12035-026-05768-1
Yuan, Y., Zhu, B., Yang, L., Leng, Y., Chen, F., Yang, Z., Gu, W., & Zhang, K. (2026) · Biomedicines · doi:10.3390/biomedicines14050986
Pdcd4–Rictor interaction suppresses mTORC2-PFKFB3 axis and tumorigenesis in NSCLC
Wang, Q., Xin, Y., Zokaei, E., Zeng, L., Piecoro, D. W., Chen, M., Zhang, Y., Yang, K. S., Wang, C., Liu, X., et al. (2026) · Neoplasia · doi:10.1016/j.neo.2026.101354
Self-citation
- Authors
- Wang, Q., Zhu, J., Wang, Y.-W., Dai, Y., Wang, Y.-L., Wang, C., Liu, J., Baker, A., Colburn, N. H., & Yang, H.-S.
- Affiliations
- University of Kentucky (US)
- Shandong University (CN)
- Qilu Hospital of Shandong University (CN)
- National Cancer Institute (US)
- Corresponding author
- Zhu, J
- Yang, H-S
- Venue
- Oncogene
- Published
- 2017-07-10
- Volume
- 36
- Issue
- 45
- Pages
- 6225-6234
- ISSN
- 0950-9232 (ISSN-L)
- 1476-5594
- PMC
- PMC5680133
- OpenAlex
- W2735343979
- Cited by
- 67
- References
- 50
- Citations by year
- 2026: 4 · 2025: 6 · 2024: 8 · 2023: 4 · 2022: 4 · 2021: 9 · 2020: 17 · 2019: 6 · 2018: 8
- FWCI
- 3.46
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- Oncogene (publishedVersion)
- PubMed (publishedVersion)
- Europe PMC (PubMed Central) (acceptedVersion)
- PubMed Central (acceptedVersion)
- UKnowledge (University of Kentucky) (submittedVersion)
- Funders
- National Cancer Institute (R03CA187839, R01CA129015, P30CA177558)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › PI3K/AKT/mTOR signaling in cancer
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Mechanisms of cancer metastasis
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › RNA and protein synthesis mechanisms
- Keywords
- PDCD4, SIN-1, mTORC2, eIF4A, translational regulation, 5' untranslated region, colorectal cancer, tumor invasion, snails, silvestrol, tumor suppressor
- MeSH terms
- Mechanistic Target of Rapamycin Complex 2, Animals, Carrier Proteins, Colonic Neoplasms, Humans, Mice, Nude, Neoplasm Invasiveness, Transfection, Protein Biosynthesis, Genes, Tumor Suppressor, RNA-Binding Proteins, Mice, Knockout, HT29 Cells, Eukaryotic Initiation Factor-4A, HCT116 Cells, Cell Line, Tumor, Adaptor Proteins, Signal Transducing, Apoptosis Regulatory Proteins, Mice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review